CompletedNot Applicable

Development and Validation of Pediatric Narcolepsy Patient Reported Outcomes Scale

United States212 participantsStarted 2019-04-02

Plain-language summary

The purpose of this study is to test a pediatric narcolepsy patient reported outcomes tool to assess pediatric narcolepsy symptoms and their effect on daily functioning and quality of life. The goal is to develop a clinical survey that can improve the care of pediatric narcolepsy.

Who can participate

Age range9 Years – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children and adolescents ages 9-17 * Have a diagnosis of narcolepsy type 1, narcolepsy type 2, or mild to moderate obstructive sleep apnea (OSA) Exclusion Criteria: * A history of visual or hearing impairment * A co-morbid neurodevelopmental disorder such as autism or schizophrenia * No access to computer/tablet/smart phone to complete questionnaires

What they're measuring

Survey Validation

Timeframe: 2 Years

Trial details

NCT IDNCT05373979

SponsorBoston Children's Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-05-30

View on ClinicalTrials.gov More Narcolepsy trials